4.8 Article

Gene silencing by synthetic U1 Adaptors

Journal

NATURE BIOTECHNOLOGY
Volume 27, Issue 3, Pages 257-263

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.1525

Keywords

-

Funding

  1. National Institutes of Health [GM057286, CA119934, R43GM085863]
  2. Gunderson lab
  3. Rutgers University/University of Medicine and Dentistry New Jersey RNA community
  4. IDT corporation
  5. NATIONAL CANCER INSTITUTE [R21CA119934] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM085863, R01GM057286] Funding Source: NIH RePORTER

Ask authors/readers for more resources

We describe a gene silencing method that employs a mechanism of action distinct from those of antisense and RNA interference. U1 Adaptors are bifunctional oligonucleotides with a 'target domain' complementary to a site in the target gene's terminal exon and a 'U1 domain' that binds to the U1 small nuclear RNA component of the U1 small nuclear ribonucleoprotein (U1 snRNP) splicing factor. Tethering of U1 snRNP to the target pre-mRNA inhibits poly(A)-tail addition, causing degradation of that RNA species in the nucleus. U1 Adaptors can inhibit both endogenous and reporter genes in a sequence-specific manner. Comparison of U1 Adaptors with small interfering RNA (siRNA) using a genome-wide microarray analysis indicates that U1 Adaptors have limited off-target effects and no detectable adverse effects on splicing. Further, targeting the same gene either with multiple U1 Adaptors or with a U1 Adaptor and siRNA strongly enhances gene silencing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available